Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | +7.74% | +6.03% | +3.73% |
04-29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
03-08 | Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bearish | Neutral |
Resistance | 3.340 | 3.340 | 3.970 |
Spread/Res. | +0.00% | +0.00% | -15.87% |
Spread/Supp. | +5.03% | +22.79% | +22.79% |
Support | 3.180 | 2.720 | 2.720 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- OVID Stock
- Charts Ovid Therapeutics Inc.